1. Home
  2. SRZN

SRZN

Surrozen Inc.

Logo Surrozen Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-23-2024 2:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Founded: 2015 Country:
United States
United States
Employees: 42 City: SOUTH SAN FRANCISCO
Market Cap: 29.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 17.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -21.33 EPS Growth: N/A
52 Week Low/High: $4.50 - $16.19 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: